David A. Broecker
Founder at Zorion Medical, Inc.
Profile
David A.
Broecker is the founder of Zorion Medical, Inc. (founded in 2010) and holds the title of President.
He is currently the Chief Executive Officer & Director at Apexian Pharmaceuticals, Inc. since 2013 and a Trustee at Wabash College.
In the past, he served as the President & Chief Executive Officer of Alkermes, Inc. from 2001 to 2009.
He was also the President, Chief Executive Officer & Director of Alkermes Plc, the Chief Executive Officer of BioCritica, Inc., and the Marketing Director of Abbott Cardiovascular Systems, Inc. From 1985 to 2001, he worked at Eli Lilly & Co. as the General Manager-Packaging & Distribution.
He also held the position of President-Research Models & Services at Harlan Laboratories, Inc. and President, Chief Executive & Operating Officer at Indiana Biosciences Research Institute.
Mr. Broecker's education includes a graduate degree from Massachusetts Institute of Technology, an MBA from The University of Chicago, and an undergraduate degree from Wabash College.
David A. Broecker active positions
| Companies | Position | Start |
|---|---|---|
Zorion Medical, Inc.
 Zorion Medical, Inc. Medical SpecialtiesHealth Technology Zorion Medical, Inc. develops absorbable medical device platform targeting treatment of coronary and peripheral artery disease. Its product includes absorbable drug-eluting stent, which is developed to treat cardiovascular diseases. The company was founded by Yanni Pandelidis, David A. Broecker and Mark C. Steckel in 2010 and is headquartered in Zionsville, IN. | Founder | 2009-12-31 |
Wabash College
 Wabash College Other Consumer ServicesConsumer Services Wabash College is an independent, liberal arts college for men. It offers qualified young men a superior education, fostering, in particular, independent intellectual inquiry, critical thought, and clear written and oral expression. The College educates its students broadly in the traditional curriculum of the liberal arts, while also requiring them to pursue concentrated study in one or more disciplines | Director/Board Member | 2011-05-23 |
Apexian Pharmaceuticals, Inc.
 Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Chief Executive Officer | 2013-04-30 |
Former positions of David A. Broecker
| Companies | Position | End |
|---|---|---|
Indiana Biosciences Research Institute
 Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Chief Executive Officer | 2017-09-30 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | President | 2009-09-09 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2000-12-31 |
| ALKERMES PLC | Chief Executive Officer | - |
Harlan Laboratories, Inc.
 Harlan Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Training of David A. Broecker
| Massachusetts Institute of Technology | Graduate Degree |
| The University of Chicago | Masters Business Admin |
| Wabash College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ALKERMES PLC | Health Technology |
| Private companies | 7 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Abbott Cardiovascular Systems, Inc.
 Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. | Health Technology |
Harlan Laboratories, Inc.
Harlan Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN. | Commercial Services |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Health Technology |
BioCritica, Inc.
 BioCritica, Inc. Pharmaceuticals: MajorHealth Technology BioCritica is a biotechnology company focused on meeting the critical care needs of patients and clinicians in the hospital market. Simply stated, their mission is to develop and commercialize products that make a dramatic improvement in people's lives. In addition to Xigris for the treatment of severe sepsis, BioCritica is developing a pipeline of other products. The company is headquartered in Indianapolis, IN. | Health Technology |
Zorion Medical, Inc.
Zorion Medical, Inc. Medical SpecialtiesHealth Technology Zorion Medical, Inc. develops absorbable medical device platform targeting treatment of coronary and peripheral artery disease. Its product includes absorbable drug-eluting stent, which is developed to treat cardiovascular diseases. The company was founded by Yanni Pandelidis, David A. Broecker and Mark C. Steckel in 2010 and is headquartered in Zionsville, IN. | Health Technology |
Indiana Biosciences Research Institute
Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Commercial Services |
- Stock Market
- Insiders
- David A. Broecker
